Ryu YJ - Search Results

1

Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells In Vitro.

Pham DH, Kim JS, Kim SK, Shin DJ, Uong NT, Hyun H, Yoon MS, Kang SJ, Ryu YJ, Cho JS, Yoon JH, Lee JS, Cho D, Lee SH, Park MH. Pham DH, et al. Among authors: ryu yj. Anticancer Res. 2017 Oct;37(10):5507-5513. doi: 10.21873/anticanres.11981. Anticancer Res. 2017. PMID: 28982863

2

Malignant thyroid bed mass after total thyroidectomy.

Park DS, Cho JS, Park MH, Ryu YJ, Hwang MJ, Shin SH, Kim HK, Lim HS, Lee JS, Yoon JH. Park DS, et al. Among authors: ryu yj. J Korean Surg Soc. 2013 Sep;85(3):97-103. doi: 10.4174/jkss.2013.85.3.97. Epub 2013 Aug 26. J Korean Surg Soc. 2013. PMID: 24020017 Free PMC article.

3

Atypia of undetermined significance on thyroid fine needle aspiration: surgical outcome and risk factors for malignancy.

Ryu YJ, Jung YS, Yoon HC, Hwang MJ, Shin SH, Cho JS, Lee JS, Kim HK, Kang HC, Lim HS, Yoon JH, Park MH. Ryu YJ, et al. Ann Surg Treat Res. 2014 Mar;86(3):109-14. doi: 10.4174/astr.2014.86.3.109. Epub 2014 Feb 24. Ann Surg Treat Res. 2014. PMID: 24761418 Free PMC article.

4

Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy.

Ryu YJ, Kang SJ, Cho JS, Yoon JH, Park MH. Ryu YJ, et al. Medicine (Baltimore). 2018 Jul;97(30):e11647. doi: 10.1097/MD.0000000000011647. Medicine (Baltimore). 2018. PMID: 30045313 Free PMC article.

5

Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.

Ryu YJ, Cho JS, Yoon JH, Park MH. Ryu YJ, et al. World J Surg Oncol. 2018 Oct 12;16(1):205. doi: 10.1186/s12957-018-1496-1. World J Surg Oncol. 2018. PMID: 30314503 Free PMC article.

6

Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.

Ryu YJ, Kang SJ, Cho JS, Yoon JH, Park MH. Ryu YJ, et al. Medicine (Baltimore). 2018 Dec;97(51):e13435. doi: 10.1097/MD.0000000000013435. Medicine (Baltimore). 2018. PMID: 30572443 Free PMC article.

7

Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.

Ryu YJ, Cho JS, Park MH, Yoon JH. Ryu YJ, et al. BMC Surg. 2019 Jul 5;19(1):78. doi: 10.1186/s12893-019-0541-5. BMC Surg. 2019. PMID: 31277631 Free PMC article.

8

Impact of prophylactic unilateral central neck dissection needed for patients with papillary thyroid microcarcinoma.

Ryu YJ, Yoon JH. Ryu YJ, et al. Gland Surg. 2020 Apr;9(2):352-361. doi: 10.21037/gs.2020.03.03. Gland Surg. 2020. PMID: 32420259 Free PMC article.

9

Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer.

Ryu YJ, Yoon JH. Ryu YJ, et al. Surg Oncol. 2020 Sep;34:67-73. doi: 10.1016/j.suronc.2020.03.008. Epub 2020 Apr 1. Surg Oncol. 2020. PMID: 32891356

10

Prostate-specific membrane antigen expression predicts recurrence of papillary thyroid carcinoma after total thyroidectomy.

Ryu YJ, Lim SY, Na YM, Park MH, Kwon SY, Lee JS. Ryu YJ, et al. BMC Cancer. 2022 Dec 7;22(1):1278. doi: 10.1186/s12885-022-10375-z. BMC Cancer. 2022. PMID: 36476583 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page